structure_rank,hugo_name,uniprot_id,uniprot_isoform,structure_id,deposition_date,experimental_method,resolution,complex_protein,complex_protein_details,complex_nucleotide,complex_nucleotide_details,complex_ligand,complex_ligand_details,chains,coverage,mutations_in_pdb,warnings
0,FKBP1A,P62942,1,AF-P62942-F1-model_v4,2022-06-01,Predicted,NA,NA,NA,NA,NA,NA,NA,A,"[(1, 108)]",NA,NA
1,FKBP1A,P62942,1,2PPN,2007-04-30,X-RAY DIFFRACTION,0.92,NA,NA,NA,NA,NA,NA,A,"[(2, 108)]",NA,
2,FKBP1A,P62942,1,2PPP,2007-04-30,X-RAY DIFFRACTION,0.94,NA,NA,NA,NA,NA,NA,A,"[(2, 108)]",['E61Q'],
3,FKBP1A,P62942,1,6YF3,2020-03-25,X-RAY DIFFRACTION,1,NA,NA,NA,NA,Other ligands,"(1~{R},9~{S},12~{S},13~{R},14~{S},17~{R},18~{E},21~{S},23~{S},24~{R},25~{S},27~{R})-17-ethyl-25-methoxy-12-[(~{E})-1-[(1~{R},3~{R},4~{R})-3-methoxy-4-oxidanyl-cyclohexyl]prop-1-en-2-yl]-13,19,21,27-tetramethyl-1,14,23-tris(oxidanyl)-11,28-dioxa-4-azatricyclo[22.3.1.0^{4,9}]octacos-18-ene-2,3,10,16-tetrone, chain A;CADMIUM ION, chain A;CHLORIDE ION, chain A;SODIUM ION, chain A",A,"[(1, 108)]",['M1P'],NA
4,FKBP1A,P62942,1,6YF2,2020-03-25,X-RAY DIFFRACTION,1.03,NA,NA,NA,NA,Other ligands,"(1~{R},9~{S},12~{S},13~{R},14~{S},17~{R},18~{E},21~{S},23~{S},24~{R},25~{S},27~{R})-23,25-dimethoxy-12-[(~{E})-1-[(1~{R},3~{R},4~{R})-3-methoxy-4-oxidanyl-cyclohexyl]prop-1-en-2-yl]-13,19,21,27-tetramethyl-1,14-bis(oxidanyl)-17-(2-oxidanylidenepropyl)-11,28-dioxa-4-azatricyclo[22.3.1.0^{4,9}]octacos-18-ene-2,3,10,16-tetrone, chain A;CADMIUM ION, chain A;CHLORIDE ION, chain A;SODIUM ION, chain A",A,"[(1, 108)]",['M1P'],NA
5,FKBP1A,P62942,1,6YF1,2020-03-25,X-RAY DIFFRACTION,1.12,NA,NA,NA,NA,Other ligands,"['(1aR,3R,5S,6R,7S,9R,10R,17aS,20S,21R,22S,25R,25aR)-25-Ethyl-10,22-dihydroxy-20-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-5,7-dimethoxy-1a,3,9,21-tetramethyloctadecahydro-2H-6,10-epoxyoxireno[p]pyrido[2,1-c][1,4]oxazacyclotricosine-11,12,18,24(1aH,14H)-tetrone, chain A']",A,"[(2, 108)]",NA,NA
6,FKBP1A,P62942,1,4N19,2013-10-03,X-RAY DIFFRACTION,1.2,NA,NA,NA,NA,Other ligands,"['SULFATE ION, chain A']",A,"[(2, 108)]","['C23V', 'G90P']",
7,FKBP1A,P62942,1,2PPO,2007-04-30,X-RAY DIFFRACTION,1.29,NA,NA,NA,NA,NA,NA,A,"[(2, 108)]",['E61A'],
8,FKBP1A,P62942,1,6I1S,2018-10-30,X-RAY DIFFRACTION,1.52,protein complex,"['FKB1A_HUMAN, P62942, chain_B;ACVR1_HUMAN, Q04771, chain_A']",NA,NA,Other ligands,"(4~{S},5~{R},6~{Z},9~{S},10~{S},12~{E})-16-(ethylamino)-4,5-dimethyl-9,10,18-tris(oxidanyl)-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione, chain A;1,2-ETHANEDIOL, chain A;SULFATE ION, chain A",B,"[(1, 108)]",NA,attachment at N-terminal with length 1 have been removed from coverage
9,FKBP1A,P62942,1,6YF0,2020-03-25,X-RAY DIFFRACTION,1.55,NA,NA,NA,NA,Other ligands,"18-HYDROXYASCOMYCIN, chain A;SULFATE ION, chain A",A,"[(2, 108)]",NA,NA
10,FKBP1A,P62942,1,1BKF,1995-10-18,X-RAY DIFFRACTION,1.6,NA,NA,NA,NA,Other ligands,"['8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN, chain A']",A,"[(2, 108)]","['R43K', 'H88V']",
11,FKBP1A,P62942,1,6VCU,2019-12-23,X-RAY DIFFRACTION,1.69,NA,NA,NA,NA,Other ligands,"ACETATE ION, chain A,B,D;N'-[(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-1,20,21-trioxo-8-(prop-2-en-1-yl)-1,3,4,5,6,8,11,12,13,14,15,16,17,18,19,20,21,23,24,25,26,26a-docosahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosin-7-ylidene]acetohydrazide, chain A,B,C,D",B;C;D;A,"[(2, 108)];[(1, 108)];[(1, 108)];[(2, 108)]",NA,NA
12,FKBP1A,P62942,1,4IPX,2013-01-10,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"['(4S)-2-METHYL-2,4-PENTANEDIOL, chain A']",A,"[(2, 108)]","['C23V', 'H88V']",
13,FKBP1A,P62942,1,2DG9,2006-03-09,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"RAPAMYCIN IMMUNOSUPPRESSANT DRUG, chain A;GLYCEROL, chain A",A,"[(2, 108)]",['W60L'],
14,FKBP1A,P62942,1,2DG3,2006-03-08,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"RAPAMYCIN IMMUNOSUPPRESSANT DRUG, chain A;GLYCEROL, chain A",A,"[(2, 108)]",NA,
15,FKBP1A,P62942,1,2DG4,2006-03-08,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"RAPAMYCIN IMMUNOSUPPRESSANT DRUG, chain A;GLYCEROL, chain A",A,"[(2, 108)]",['W60F'],
16,FKBP1A,P62942,1,1FKJ,1995-08-18,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"['8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN, chain A']",A,"[(2, 108)]",NA,
17,FKBP1A,P62942,1,1FKB,1992-07-02,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"['RAPAMYCIN IMMUNOSUPPRESSANT DRUG, chain A']",A,"[(2, 108)]",NA,
18,FKBP1A,P62942,1,1FKF,1991-05-07,X-RAY DIFFRACTION,1.7,NA,NA,NA,NA,Other ligands,"['8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN, chain A']",A,"[(2, 108)]",NA,
19,FKBP1A,P62942,1,2FKE,1993-01-27,X-RAY DIFFRACTION,1.72,NA,NA,NA,NA,Other ligands,"['8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN, chain A']",A,"[(2, 108)]",NA,
20,FKBP1A,P62942,1,1FKD,1992-12-02,X-RAY DIFFRACTION,1.72,NA,NA,NA,NA,Other ligands,"['18-HYDROXYASCOMYCIN, chain A']",A,"[(2, 108)]",NA,
21,FKBP1A,P62942,1,4ODP,2014-01-10,X-RAY DIFFRACTION,1.747,fusion product in protein complex,"['RS2_ECOLI, P0A7V0, chain_B;FKB1A_HUMAN, P62942, chain_A;Q5SLE7_THET8, Q5SLE7, chain_A']",NA,NA,Other ligands,"CHLORIDE ION, chain A;CALCIUM ION, chain A;NICKEL (II) ION, chain A",A,"[(0, 0);(52, 82);(92, 108)]","['K53H', 'Q54R', 'E55N', 'V56L', 'R58P', 'W60L', 'G63A', 'V64L', 'A65E', 'Q66G', 'M67R', 'S68E', 'V69E', 'Q71E', 'R72A', 'A73F', 'K74Q', 'L75A', 'T76H', 'I77V', 'S78P', 'P79A', 'D80E', 'Y81K', 'V99D', 'D101Q', 'L104V', 'L105V', 'L107V', 'E108R', '-0E', '-0A', '-0T', '-0P', '-0E', '-0E', '-0L', '-0L', '-0H', '-0G', '-0H', '-0A', '-0H', '-0P', '-0S', '-0G', '-0H', '-0H', '-0H', '-0H', '-0H', '-0H']",attachment at N-terminal with length 31 have been removed from coverage
22,FKBP1A,P62942,1,1J4R,2001-10-29,X-RAY DIFFRACTION,1.8,NA,NA,NA,NA,Other ligands,"1-[2,2-DIFLUORO-2-(3,4,5-TRIMETHOXY-PHENYL)-ACETYL]-PIPERIDINE-2-CARBOXYLIC ACID 4-PHENYL-1-(3-PYRIDIN-3-YL-PROPYL)-BUTYL ESTER, chain A,B,D;GLYCEROL, chain A;SULFATE ION, chain B,D",B;D;A,"[(2, 108)];[(2, 108)];[(2, 108)]",NA,;;
23,FKBP1A,P62942,1,1J4H,2001-09-30,X-RAY DIFFRACTION,1.8,NA,NA,NA,NA,Other ligands,"['3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)-THIOMORPHOLINE-3-CARBONYL]-AMINO}-PROPIONIC ACID ETHYL ESTER, chain A']",A,"[(2, 108)]",NA,
24,FKBP1A,P62942,1,1J4I,2001-09-30,X-RAY DIFFRACTION,1.8,NA,NA,NA,NA,Other ligands,"['4-METHYL-2-{[4-(TOLUENE-4-SULFONYL)-THIOMORPHOLINE-3-CARBONYL]-AMINO}-PENTANOIC ACID, chain A']",A,"[(2, 108)]",NA,
25,FKBP1A,P62942,1,1D7J,1999-10-18,X-RAY DIFFRACTION,1.85,NA,NA,NA,NA,Other ligands,"AMMONIUM ION, chain A,B;SULFATE ION, chain A,B;4-HYDROXY-2-BUTANONE, chain A,B",B;A,"[(2, 108)];[(2, 108)]",NA,;
26,FKBP1A,P62942,1,1D6O,1999-10-15,X-RAY DIFFRACTION,1.85,NA,NA,NA,NA,Other ligands,"AMMONIUM ION, chain A,B;SULFATE ION, chain A,B",B;A,"[(2, 108)];[(2, 108)]",NA,;
27,FKBP1A,P62942,1,3FAP,1999-05-06,X-RAY DIFFRACTION,1.85,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"['C15-(R)-METHYLTHIENYL RAPAMYCIN, chain A']",A,"[(2, 108)]",NA,
28,FKBP1A,P62942,1,5I7Q,2016-02-18,X-RAY DIFFRACTION,1.9,fusion product,"['FKB1A_HUMAN, P62942, chain_A;FKBX_ECOLI, P0AEM0, chain_A']",NA,NA,NA,NA,A,"[(0, 0);(2, 108)]","['C23A', 'A85V', 'T86P', 'G87S', 'H88P', 'P89D', 'G90L', 'I92Q', 'P93Y', 'P94F', 'H95S', 'A96R', 'T97R', 'L98E', 'V99F', 'F100M', 'V102A', 'E103G', 'L104E', 'L105P', 'K106E', 'L107I', 'E108G', '-0A', '-0I', '-0M', '-0L', '-0F', '-0T', '-0A', '-0M', '-0D', '-0G', '-0S', '-0E', '-0M', '-0P', '-0G', '-0V', '-0I', '-0R', '-0E', '-0I', '-0N', '-0G', '-0D', '-0S', '-0I', '-0T', '-0V', '-0D', '-0F', '-0N', '-0H', '-0P', '-0L', '-0A', '-0G', '-0Q', '-0T', '-0L', '-0V', '-0F', '-0D', '-0V', '-0E', '-0L', '-0L', '-0K', '-0L', '-0E', '-0A']","The structure likely contains an expression tag,"
29,FKBP1A,P62942,1,1D7H,1999-10-18,X-RAY DIFFRACTION,1.9,NA,NA,NA,NA,Other ligands,"AMMONIUM ION, chain A,B;SULFATE ION, chain A,B;DIMETHYL SULFOXIDE, chain A,B",B;A,"[(2, 108)];[(2, 108)]",NA,;
30,FKBP1A,P62942,1,1D7I,1999-10-18,X-RAY DIFFRACTION,1.9,NA,NA,NA,NA,Other ligands,"AMMONIUM ION, chain A,B;SULFATE ION, chain A,B;METHYL METHYLSULFINYLMETHYL SULFIDE, chain A,B",B;A,"[(2, 108)];[(2, 108)]",NA,;
31,FKBP1A,P62942,1,1BL4,1998-07-23,X-RAY DIFFRACTION,1.9,NA,NA,NA,NA,Other ligands,"['{3-[3-(3,4-DIMETHOXY-PHENYL)-1-(1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)-PROPYL]-PHENOXY}-ACETIC ACID, chain A,B']",B;A,"[(2, 108)];[(2, 108)]",['F37V'];['F37V'],;
32,FKBP1A,P62942,1,4ODR,2014-01-10,X-RAY DIFFRACTION,1.929,fusion product,"['FKB1A_HUMAN, P62942, chain_A;Q5SLE7_THET8, Q5SLE7, chain_A']",NA,NA,Other ligands,"8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN, chain A,B;ZINC ION, chain A,B;CHLORIDE ION, chain A,B;GLYCEROL, chain A,B;ACETATE ION, chain A,B",B;A,"[(0, 0);(52, 108)];[(0, 0);(52, 108)]","['K53H', 'Q54R', 'E55N', 'V56L', 'R58P', 'W60L', 'G63A', 'V64L', 'A65E', 'Q66G', 'M67R', 'S68E', 'V69E', 'Q71E', 'R72A', 'A73F', 'K74Q', 'L75A', 'T76H', 'I77V', 'S78P', 'P79A', 'D80E', 'Y81K', 'V99D', 'D101Q', 'L104V', 'L105V', 'L107V', 'E108R', '-0E', '-0A', '-0T', '-0P', '-0E', '-0E', '-0L', '-0L', '-0H', '-0G', '-0H', '-0A', '-0H', '-0P', '-0S', '-0G', '-0H'];['K53H', 'Q54R', 'E55N', 'V56L', 'R58P', 'W60L', 'G63A', 'V64L', 'A65E', 'Q66G', 'M67R', 'S68E', 'V69E', 'Q71E', 'R72A', 'A73F', 'K74Q', 'L75A', 'T76H', 'I77V', 'S78P', 'P79A', 'D80E', 'Y81K', 'V99D', 'D101Q', 'L104V', 'L105V', 'L107V', 'E108R', '-0E', '-0A', '-0T', '-0P', '-0E', '-0E', '-0L', '-0L', '-0H', '-0G', '-0H', '-0A', '-0H', '-0P', '-0S', '-0G']","The structure likely contains an expression tag,attachment at N-terminal with length 31 have been removed from coverage;The structure likely contains an expression tag,attachment at N-terminal with length 31 have been removed from coverage"
33,FKBP1A,P62942,1,1FKH,1993-08-05,X-RAY DIFFRACTION,1.95,NA,NA,NA,NA,Other ligands,"['1-CYCLOHEXYL-3-PHENYL-1-PROPYL-1-(3,3-DIMETHYL-1,2-DIOXYPENTYL)-2-PIPERIDINE CARBOXYLATE, chain A']",A,"[(2, 108)]",NA,
34,FKBP1A,P62942,1,4ODQ,2014-01-10,X-RAY DIFFRACTION,2,fusion product in protein complex,"['FKB1A_HUMAN, P62942, chain_A;RS3_ECOLI, P0A7V3, chain_B;Q5SLE7_THET8, Q5SLE7, chain_A']",NA,NA,Other ligands,"CHLORIDE ION, chain A;CALCIUM ION, chain A;NICKEL (II) ION, chain A",A,"[(0, 0);(52, 88);(93, 108)]","['K53H', 'Q54R', 'E55N', 'V56L', 'R58P', 'W60L', 'G63A', 'V64L', 'A65E', 'Q66G', 'M67R', 'S68E', 'V69E', 'Q71E', 'R72A', 'A73F', 'K74Q', 'L75A', 'T76H', 'I77V', 'S78P', 'P79A', 'D80E', 'Y81K', 'V99D', 'D101Q', 'L104V', 'L105V', 'L107V', 'E108R', '-0E', '-0A', '-0T', '-0P', '-0E', '-0E', '-0L', '-0L', '-0H', '-0G', '-0H', '-0A', '-0H', '-0P', '-0S', '-0G', '-0H', '-0H', '-0H', '-0H', '-0H', '-0H']",attachment at N-terminal with length 31 have been removed from coverage
35,FKBP1A,P62942,1,1EYM,2000-05-07,X-RAY DIFFRACTION,2.0,NA,NA,NA,NA,NA,NA,B;A,"[(2, 108)];[(2, 108)]",['F37M'];['F37M'],;
36,FKBP1A,P62942,1,1A7X,1998-03-18,X-RAY DIFFRACTION,2.0,NA,NA,NA,NA,Other ligands,"['BENZYL-CARBAMIC ACID [8-DEETHYL-ASCOMYCIN-8-YL]ETHYL ESTER, chain B']",B;A,"[(2, 108)];[(2, 108)]",NA,;
37,FKBP1A,P62942,1,1FKG,1993-08-05,X-RAY DIFFRACTION,2,NA,NA,NA,NA,Other ligands,"['1,3-DIPHENYL-1-PROPYL-1-(3,3-DIMETHYL-1,2-DIOXYPENTYL)-2-PIPERIDINE CARBOXYLATE, chain A']",A,"[(2, 108)]",NA,
38,FKBP1A,P62942,1,5I7P,2016-02-18,X-RAY DIFFRACTION,2.002,fusion product,"['SLYD_ECOLI, P0A9K9, chain_A;FKB1A_HUMAN, P62942, chain_A']",NA,NA,NA,NA,A,"[(0, 0);(2, 108)]","['C23A', 'A85Q', 'T86Y', 'G87D', 'H88E', 'P89N', 'G90L', 'I91V', 'I92Q', 'P93R', 'P94V', 'H95P', 'A96K', 'T97D', 'L98V', 'V99F', 'F100M', 'D101G', 'E103D', 'L104E', 'K106Q', 'L107V', 'E108G', '-0M', '-0R', '-0F', '-0L', '-0A', '-0E', '-0T', '-0D', '-0Q', '-0G', '-0P', '-0V', '-0P', '-0V', '-0E', '-0I', '-0T', '-0A', '-0V', '-0E', '-0D', '-0D', '-0H', '-0V', '-0V', '-0V', '-0D', '-0G', '-0N', '-0H', '-0M', '-0L', '-0A', '-0G', '-0Q', '-0N', '-0L', '-0V', '-0F', '-0D', '-0V', '-0E', '-0L', '-0L', '-0K', '-0L', '-0E', '-0A']","The structure likely contains an expression tag,"
39,FKBP1A,P62942,1,3MDY,2010-03-31,X-RAY DIFFRACTION,2.05,protein complex,"['FKB1A_HUMAN, P62942, chain_B;BMR1B_HUMAN, O00238, chain_A']",NA,NA,Other ligands,"['4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline, chain A,C']",B;D,"[(1, 108)];[(1, 108)]",NA,"attachment at N-terminal with length 1 have been removed from coverage;,attachment at N-terminal with length 1 have been removed from coverage"
40,FKBP1A,P62942,1,4DH0,2012-01-27,X-RAY DIFFRACTION,2.1,NA,NA,NA,NA,Other ligands,"['28-O-Methylrapamycin, chain A']",A,"[(2, 108)]",NA,
41,FKBP1A,P62942,1,6M4U,2020-03-09,X-RAY DIFFRACTION,2.2,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"RAPAMYCIN IMMUNOSUPPRESSANT DRUG, chain A,E;ZINC ION, chain A,B,E,F;CHLORIDE ION, chain A,B,E,F;GLYCEROL, chain F",E;A,"[(1, 108)];[(1, 108)]",NA,"attachment at N-terminal with length 2 have been removed from coverage;,"
42,FKBP1A,P62942,1,6OQA,2019-04-26,X-RAY DIFFRACTION,2.2,protein complex,"['FKB1A_HUMAN, P62942, chain_A;CP250_HUMAN, Q9BV73, chain_C']",NA,NA,Other ligands,"(3R,4E,7E,10R,11S,12R,13S,16R,17R,24aS)-11,17-dihydroxy-10,12,16-trimethyl-3-[(2R)-1-phenylbutan-2-yl]-6,9,10,11,12,13,14,15,16,17,22,23,24,24a-tetradecahydro-3H-13,17-epoxypyrido[2,1-c][1,4]oxazacyclohenicosine-1,18,19(21H)-trione, chain A,B,E,F;1,2-ETHANEDIOL, chain A,B,C,D,E,G;DI(HYDROXYETHYL)ETHER, chain A,B,C,D,F,G,H;3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL, chain A,B;TRIETHYLENE GLYCOL, chain B,C,D,G;TETRAETHYLENE GLYCOL, chain C,G;MAGNESIUM ION, chain D;MALONIC ACID, chain H",B;E;A;F,"[(2, 108)];[(2, 108)];[(1, 108)];[(2, 108)]",NA,NA
43,FKBP1A,P62942,1,2FAP,1998-09-22,X-RAY DIFFRACTION,2.2,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"['C49-METHYL RAPAMYCIN, chain A']",A,"[(2, 108)]",NA,
44,FKBP1A,P62942,1,1NSG,1997-07-01,X-RAY DIFFRACTION,2.2,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"['C49-METHYL RAPAMYCIN, chain A']",A,"[(2, 108)]",NA,
45,FKBP1A,P62942,1,1FKI,1993-08-05,X-RAY DIFFRACTION,2.2,NA,NA,NA,NA,Other ligands,"['(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE, chain A,B']",B;A,"[(2, 108)];[(2, 108)]",NA,;
46,FKBP1A,P62942,1,3H9R,2009-04-30,X-RAY DIFFRACTION,2.35,protein complex,"['FKB1A_HUMAN, P62942, chain_B;ACVR1_HUMAN, Q04771, chain_A']",NA,NA,Other ligands,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine, chain A;SULFATE ION, chain A;TETRAETHYLENE GLYCOL, chain A",B,"[(2, 108)]",NA,NA
47,FKBP1A,P62942,1,1QPF,1999-05-24,X-RAY DIFFRACTION,2.5,NA,NA,NA,NA,Other ligands,"C32-O-(1-ETHYL-INDOL-5-YL)ASCOMYCIN, chain A,D;heptyl beta-D-glucopyranoside, chain A",D;A,"[(2, 108)];[(2, 108)]",NA,;
48,FKBP1A,P62942,1,1B6C,1999-01-13,X-RAY DIFFRACTION,2.6,protein complex,"['FKB1A_HUMAN, P62942, chain_A;TGFR1_HUMAN, P36897, chain_B']",NA,NA,Other ligands,"['SULFATE ION, chain B,D,F,H']",C;G;E;A,"[(2, 108)];[(2, 108)];[(2, 108)];[(2, 108)]",NA,NA
49,FKBP1A,P62942,1,1FAP,1996-03-15,X-RAY DIFFRACTION,2.7,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"['RAPAMYCIN IMMUNOSUPPRESSANT DRUG, chain A']",A,"[(2, 108)]",NA,
50,FKBP1A,P62942,1,4FAP,1999-05-06,X-RAY DIFFRACTION,2.8,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"['C15-(R)-METHYLTHIENYL RAPAMYCIN, chain A']",A,"[(2, 108)]",NA,
51,FKBP1A,P62942,1,1QPL,1999-05-25,X-RAY DIFFRACTION,2.9,NA,NA,NA,NA,Other ligands,"['C32-O-(1-METHYL-INDOL-5-YL) 18-HYDROXY-ASCOMYCIN, chain A,C']",C;A,"[(2, 108)];[(2, 108)]",NA,;
52,FKBP1A,P62942,1,7EPD,2021-04-26,ELECTRON MICROSCOPY,3.9,fusion product in protein complex,"['FKB1A_HUMAN, P62942, chain_A;GRM7_HUMAN, Q14831, chain_B;GRM2_HUMAN, Q14416, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,NA,NA,A,"[(16, 108)]","['P17Q', 'K18A', 'R19K', 'G20A', 'Q21M', 'T22A', 'C23E', 'V24I', 'V25L', 'H26R', 'Y27F', 'T28F', 'G29N', 'M30W', 'L31T', 'E32Y', 'D33V', 'G34S', 'K35T', 'K36V', 'F37A', 'D38S', 'S39E', 'S40G', 'R41D', 'D42Y', 'R43G', 'N44E', 'K45T', 'P46G', 'F47I', 'K48E', 'F49A', 'M50F', 'L51E', 'G52L', 'K53E', 'Q54A', 'E55R', 'V56A', 'I57R', 'R58N', 'G59I', 'W60C', 'E61V', 'E62A', 'G63T', 'V64S', 'A65E', 'Q66K', 'M67V', 'S68G', 'V69R', 'G70A', 'Q71M', 'R72S', 'A73R', 'K74A', 'L75A', 'T76F', 'I77E', 'S78G', 'P79V', 'D80V', 'Y81R', 'Y83L', 'G84L', 'A85Q', 'T86K', 'G87P', 'H88S', 'P89A', 'G90R', 'I91V', 'I92A', 'P93V', 'P94L', 'H95F', 'A96T', 'T97R', 'L98S', 'V99E', 'F100D', 'D101A', 'V102R', 'K106A', 'L107A', 'E108S']","The structure likely contains an expression tag,attachment at N-terminal with length 144 have been removed from coverage, attachment at N-terminal with length 16 have been removed from coverage, attachment at C-terminal with length 16 have been removed from coverage"
53,FKBP1A,P62942,1,2ND5,2016-05-05,SOLUTION NMR,NA,NA,NA,NA,NA,NA,NA,A,"[(1, 17);(19, 34);(37, 44);(46, 47);(49, 52);(54, 73);(75, 105);(107, 108)]",NA,attachment at N-terminal with length 3 have been removed from coverage
54,FKBP1A,P62942,1,2RSE,2012-01-25,SOLUTION NMR,NA,protein complex,"['FKB1A_HUMAN, P62942, chain_A;MTOR_HUMAN, P42345, chain_B']",NA,NA,Other ligands,"['TERBIUM(III) ION, chain A']",A,"[(2, 108)]",NA,
55,FKBP1A,P62942,1,1F40,2000-06-07,SOLUTION NMR,NA,NA,NA,NA,NA,Other ligands,"['(2S)-[3-PYRIDYL-1-PROPYL]-1-[3,3-DIMETHYL-1,2-DIOXOPENTYL]-2-PYRROLIDINECARBOXYLATE, chain A']",A,"[(2, 108)]",NA,
56,FKBP1A,P62942,1,1FKR,1992-03-05,SOLUTION NMR,NA,NA,NA,NA,NA,NA,NA,A,"[(2, 108)]",NA,
57,FKBP1A,P62942,1,1FKS,1992-03-05,SOLUTION NMR,NA,NA,NA,NA,NA,NA,NA,A,"[(2, 108)]",NA,
58,FKBP1A,P62942,1,1FKT,1992-03-05,SOLUTION NMR,NA,NA,NA,NA,NA,NA,NA,A,"[(2, 108)]",NA,
